116 related articles for article (PubMed ID: 29277774)
1. Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis.
Jarząb A; Łuszczki J; Guz M; Skalicka-Woźniak K; Hałasa M; Smok-Kalwat J; Polberg K; Stepulak A
Anticancer Res; 2018 Jan; 38(1):205-210. PubMed ID: 29277774
[TBL] [Abstract][Full Text] [Related]
2. Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells - An Isobolographic Analysis.
Jarząb A; Łuszczki JJ; Guz M; Gumbarewicz E; Polberg K; Stepulak A
Anticancer Res; 2017 Mar; 37(3):1067-1074. PubMed ID: 28314266
[TBL] [Abstract][Full Text] [Related]
3. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells.
Wróblewska-Łuczka P; Grabarska A; Florek-Łuszczki M; Plewa Z; Łuszczki JJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430369
[TBL] [Abstract][Full Text] [Related]
4. Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.
Okon E; Luszczki JJ; Kukula-Koch W; Halasa M; Jarzab A; Khurelbat D; Stepulak A; Wawruszak A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325867
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological features of osthole.
Jarząb A; Grabarska A; Skalicka-Woźniak K; Stepulak A
Postepy Hig Med Dosw (Online); 2017 May; 71(0):411-421. PubMed ID: 28513464
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.
Wawruszak A; Luszczki J; Halasa M; Okon E; Landor S; Sahlgren C; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068438
[TBL] [Abstract][Full Text] [Related]
9. Osthole induces apoptosis, suppresses cell-cycle progression and proliferation of cancer cells.
Jarząb A; Grabarska A; Kiełbus M; Jeleniewicz W; Dmoszyńska-Graniczka M; Skalicka-Woźniak K; Sieniawska E; Polberg K; Stepulak A
Anticancer Res; 2014 Nov; 34(11):6473-80. PubMed ID: 25368248
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
11. Effects of osthole on migration and invasion in breast cancer cells.
Yang D; Gu T; Wang T; Tang Q; Ma C
Biosci Biotechnol Biochem; 2010; 74(7):1430-4. PubMed ID: 20622464
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects between a copper-based metal Casiopeína III-ia and cisplatin.
Davila-Manzanilla SG; Figueroa-de-Paz Y; Mejia C; Ruiz-Azuara L
Eur J Med Chem; 2017 Mar; 129():266-274. PubMed ID: 28231523
[TBL] [Abstract][Full Text] [Related]
13. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T
Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
16. Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines.
Gumbarewicz E; Luszczki JJ; Wawruszak A; Dmoszynska-Graniczka M; Grabarska AJ; Jarząb AM; Polberg K; Stepulak A
Am J Cancer Res; 2016; 6(12):2831-2845. PubMed ID: 28042503
[TBL] [Abstract][Full Text] [Related]
17. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
18. Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro.
Uehara T; Mitsuhashi A; Tsuruoka N; Shozu M
Oncol Rep; 2015 Feb; 33(2):744-50. PubMed ID: 25421433
[TBL] [Abstract][Full Text] [Related]
19. Osthole enhances TRAIL-mediated apoptosis through downregulation of c-FLIP expression in renal carcinoma Caki cells.
Min KJ; Han MA; Kim S; Park JW; Kwon TK
Oncol Rep; 2017 Apr; 37(4):2348-2354. PubMed ID: 28350076
[TBL] [Abstract][Full Text] [Related]
20. Osthole shows the potential to overcome P-glycoprotein‑mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Wang JY; Li YJ
Oncol Rep; 2016 Jun; 35(6):3659-68. PubMed ID: 27109742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
